Ozempic has ‘far-reaching benefits’ beyond weight loss with people dying at lower rate from all causes
Weight-loss drugs are poised to revolutionise healthcare by slowing down the ageing process and by allowing people to live for longer and in better health. That is the dramatic message from leading scientists after studies were presented last week at the European Society of Cardiology Conference in London.
Research has already found that semaglutide – also known by the brand names Wegovy and Ozempic – reduced the risk of death in people who were obese or overweight and had cardiovascular disease.
More Stories
Elon Musk’s company town: SpaceX employees vote to create ‘Starbase’
Scientists record seismic tremors from title-clinching Liverpool win over Spurs
Please welcome to the stage … Anita Dump! The Facebook group with the best and worst drag names